Chemicals
Compare Stocks
2 / 10Stock Comparison
ORGN vs LNZA
Revenue, margins, valuation, and 5-year total return — side by side.
Waste Management
ORGN vs LNZA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals | Waste Management |
| Market Cap | $211M | $53M |
| Revenue (TTM) | $25M | $40M |
| Net Income (TTM) | $-69M | $-76M |
| Gross Margin | 1.8% | 29.0% |
| Operating Margin | -321.3% | -265.8% |
| Total Debt | $10M | $82M |
| Cash & Equiv. | $56M | $43M |
ORGN vs LNZA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Origin Materials, I… (ORGN) | 100 | 0.7 | -99.3% |
| LanzaTech Global, I… (LNZA) | 100 | 2.3 | -97.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ORGN vs LNZA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ORGN is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 8.6%, EPS growth -441.2%
- Lower volatility, beta 1.68, Low D/E 2.9%, current ratio 11.09x
- 8.6% revenue growth vs LNZA's -20.8%
LNZA carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.64
- -97.7% 10Y total return vs ORGN's -99.5%
- Beta 1.64, current ratio 3.26x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.6% revenue growth vs LNZA's -20.8% | |
| Quality / Margins | -190.2% margin vs ORGN's -275.0% | |
| Stability / Safety | Beta 1.64 vs ORGN's 1.68 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -5.2% vs ORGN's -92.8% | |
| Efficiency (ROA) | -19.7% ROA vs LNZA's -58.8%, ROIC -19.6% vs -147.7% |
ORGN vs LNZA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ORGN vs LNZA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LNZA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LNZA is the larger business by revenue, generating $40M annually — 1.6x ORGN's $25M. Profitability is closely matched — net margins range from -190.2% (LNZA) to -2.8% (ORGN). On growth, LNZA holds the edge at -6.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $25M | $40M |
| EBITDAEarnings before interest/tax | -$70M | -$102M |
| Net IncomeAfter-tax profit | -$69M | -$76M |
| Free Cash FlowCash after capex | -$55M | -$81M |
| Gross MarginGross profit ÷ Revenue | +1.8% | +29.0% |
| Operating MarginEBIT ÷ Revenue | -3.2% | -2.7% |
| Net MarginNet income ÷ Revenue | -2.8% | -190.2% |
| FCF MarginFCF ÷ Revenue | -2.2% | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -43.2% | -6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +57.7% | +103.4% |
Valuation Metrics
ORGN leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $211M | $53M |
| Enterprise ValueMkt cap + debt − cash | $164M | $91M |
| Trailing P/EPrice ÷ TTM EPS | -2.45x | -0.32x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 6.74x | 1.06x |
| Price / BookPrice ÷ Book value/share | 0.60x | 3.33x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
ORGN leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
ORGN delivers a -21.9% return on equity — every $100 of shareholder capital generates $-22 in annual profit, vs $-2 for LNZA. ORGN carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to LNZA's 6.09x. On the Piotroski fundamental quality scale (0–9), LNZA scores 3/9 vs ORGN's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -21.9% | -2.2% |
| ROA (TTM)Return on assets | -19.7% | -58.8% |
| ROICReturn on invested capital | -19.6% | -147.7% |
| ROCEReturn on capital employed | -20.8% | -60.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.03x | 6.09x |
| Net DebtTotal debt minus cash | -$47M | $38M |
| Cash & Equiv.Liquid assets | $56M | $43M |
| Total DebtShort + long-term debt | $10M | $82M |
| Interest CoverageEBIT ÷ Interest expense | -417.10x | — |
Total Returns (Dividends Reinvested)
LNZA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LNZA five years ago would be worth $229 today (with dividends reinvested), compared to $48 for ORGN. Over the past 12 months, LNZA leads with a -5.2% total return vs ORGN's -92.8%. The 3-year compound annual growth rate (CAGR) favors LNZA at -59.7% vs ORGN's -77.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -79.9% | +61.8% |
| 1-Year ReturnPast 12 months | -92.8% | -5.2% |
| 3-Year ReturnCumulative with dividends | -98.9% | -93.4% |
| 5-Year ReturnCumulative with dividends | -99.5% | -97.7% |
| 10-Year ReturnCumulative with dividends | -99.5% | -97.7% |
| CAGR (3Y)Annualised 3-year return | -77.7% | -59.7% |
Risk & Volatility
LNZA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LNZA is the less volatile stock with a 1.64 beta — it tends to amplify market swings less than ORGN's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNZA currently trades 31.8% from its 52-week high vs ORGN's 5.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.68x | 1.64x |
| 52-Week HighHighest price in past year | $28.49 | $71.19 |
| 52-Week LowLowest price in past year | $0.20 | $7.88 |
| % of 52W HighCurrent price vs 52-week peak | +5.0% | +31.8% |
| RSI (14)Momentum oscillator 0–100 | 30.7 | 46.1 |
| Avg Volume (50D)Average daily shares traded | 161K | 49K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ORGN as "Buy" and LNZA as "Hold". Consensus price targets imply 6238.0% upside for ORGN (target: $90) vs -75.7% for LNZA (target: $6).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $90.00 | $5.50 |
| # AnalystsCovering analysts | 6 | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
LNZA leads in 3 of 6 categories (Income & Cash Flow, Total Returns). ORGN leads in 2 (Valuation Metrics, Profitability & Efficiency).
ORGN vs LNZA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ORGN or LNZA a better buy right now?
For growth investors, Origin Materials, Inc.
(ORGN) is the stronger pick with 8. 6% revenue growth year-over-year, versus -20. 8% for LanzaTech Global, Inc. (LNZA). Analysts rate Origin Materials, Inc. (ORGN) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ORGN or LNZA?
Over the past 5 years, LanzaTech Global, Inc.
(LNZA) delivered a total return of -97. 7%, compared to -99. 5% for Origin Materials, Inc. (ORGN). Over 10 years, the gap is even starker: LNZA returned -97. 7% versus ORGN's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ORGN or LNZA?
By beta (market sensitivity over 5 years), LanzaTech Global, Inc.
(LNZA) is the lower-risk stock at 1. 64β versus Origin Materials, Inc. 's 1. 68β — meaning ORGN is approximately 2% more volatile than LNZA relative to the S&P 500. On balance sheet safety, Origin Materials, Inc. (ORGN) carries a lower debt/equity ratio of 3% versus 6% for LanzaTech Global, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ORGN or LNZA?
By revenue growth (latest reported year), Origin Materials, Inc.
(ORGN) is pulling ahead at 8. 6% versus -20. 8% for LanzaTech Global, Inc. (LNZA). On earnings-per-share growth, the picture is similar: LanzaTech Global, Inc. grew EPS 11. 2% year-over-year, compared to -441. 2% for Origin Materials, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ORGN or LNZA?
Origin Materials, Inc.
(ORGN) is the more profitable company, earning -267. 6% net margin versus -277. 7% for LanzaTech Global, Inc. — meaning it keeps -267. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNZA leads at -219. 7% versus -271. 3% for ORGN. At the gross margin level — before operating expenses — LNZA leads at 47. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ORGN or LNZA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is ORGN or LNZA better for a retirement portfolio?
For long-horizon retirement investors, LanzaTech Global, Inc.
(LNZA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Origin Materials, Inc. (ORGN) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LNZA: -97. 7%, ORGN: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ORGN and LNZA?
These companies operate in different sectors (ORGN (Basic Materials) and LNZA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.